Predicting the immunity landscape and prognosis with an NCLs signature in liver hepatocellular carcinoma.
Zhangxin JiChenxu ZhangJingjing YuanQing HeXinyu ZhangDongmei YangNa XuJun ChuPublished in: PloS one (2024)
Overall, we have developed a prognostic signature that can discriminate different LIHC subgroups through the 5 selected NCLs, with the objective of providing LIHC patients a more precise, personalized treatment regimen.